Clinical and statistical considerations in personalized medicine / / edited by Claudio Carini, Pfizer, Cambridge, Massachusetts, USA, Sandeep M. Menon, Pfizer, Cambridge, Massachusetts, USA, Mark Chang, AMAG Pharmaceuticals, Incorporated Waltham, Massach |
Pubbl/distr/stampa | Boca Raton : , : CRC Press, , [2014] |
Descrizione fisica | 1 online resource (368 p.) |
Disciplina |
615.7072/7
615.70727 |
Collana | Chapman and Hall/CRC Biostatistics Series |
Soggetto topico |
Pharmacogenetics - Mathematical models
Pharmacogenetics - Statistical methods Pharmacogenomics - Mathematical models Pharmacogenomics - Statistical methods |
ISBN |
0-429-16933-7
1-4665-9387-3 |
Classificazione | MAT029000MED045000MED071000 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Front Cover; Contents; Preface; Editors; Contributors; Chapter 1: Biomarkers for Drug Development: The Time Is Now!; Chapter 2: RNAi Screens: Triumphs and Tribulations; Chapter 3: Current Advances in Epigenetics; Chapter 4: Biomarkers and Precision Medicine: The Case of Rare Diseases; Chapter 5: Biomarker-Informed Adaptive Design; Chapter 6: Fitting the Dose: Adaptive Staggered Dose Design; Chapter 7: Evidence-Based Adaptive Statistical Decision and Design Strategies for; Chapter 8: Biomarker Identification in Clinical Trials; Chapter 9: Multiplicity in Pharmacogenomics
Chapter 10: Patient-Reported Outcomes in Personalized MedicineChapter 11: Regulatory Issues in Use of Biomarkers in Drug Development; Back Cover |
Record Nr. | UNINA-9910789244103321 |
Boca Raton : , : CRC Press, , [2014] | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Clinical and statistical considerations in personalized medicine / / edited by Claudio Carini, Pfizer, Cambridge, Massachusetts, USA, Sandeep M. Menon, Pfizer, Cambridge, Massachusetts, USA, Mark Chang, AMAG Pharmaceuticals, Incorporated Waltham, Massach |
Pubbl/distr/stampa | Boca Raton : , : CRC Press, , [2014] |
Descrizione fisica | 1 online resource (368 p.) |
Disciplina |
615.7072/7
615.70727 |
Collana | Chapman and Hall/CRC Biostatistics Series |
Soggetto topico |
Pharmacogenetics - Mathematical models
Pharmacogenetics - Statistical methods Pharmacogenomics - Mathematical models Pharmacogenomics - Statistical methods |
ISBN |
0-429-16933-7
1-4665-9387-3 |
Classificazione | MAT029000MED045000MED071000 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Front Cover; Contents; Preface; Editors; Contributors; Chapter 1: Biomarkers for Drug Development: The Time Is Now!; Chapter 2: RNAi Screens: Triumphs and Tribulations; Chapter 3: Current Advances in Epigenetics; Chapter 4: Biomarkers and Precision Medicine: The Case of Rare Diseases; Chapter 5: Biomarker-Informed Adaptive Design; Chapter 6: Fitting the Dose: Adaptive Staggered Dose Design; Chapter 7: Evidence-Based Adaptive Statistical Decision and Design Strategies for; Chapter 8: Biomarker Identification in Clinical Trials; Chapter 9: Multiplicity in Pharmacogenomics
Chapter 10: Patient-Reported Outcomes in Personalized MedicineChapter 11: Regulatory Issues in Use of Biomarkers in Drug Development; Back Cover |
Record Nr. | UNINA-9910806250903321 |
Boca Raton : , : CRC Press, , [2014] | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|